A detailed history of Black Rock Inc. transactions in Genmab A/S stock. As of the latest transaction made, Black Rock Inc. holds 5,080,562 shares of GMAB stock, worth $108 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,080,562
Previous 5,067,133 0.27%
Holding current value
$108 Million
Previous $152 Million 15.76%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$25.13 - $30.27 $337,470 - $406,495
13,429 Added 0.27%
5,080,562 $128 Million
Q1 2024

May 10, 2024

BUY
$26.43 - $32.77 $17.4 Million - $21.5 Million
657,558 Added 14.91%
5,067,133 $152 Million
Q4 2023

Feb 13, 2024

SELL
$27.94 - $35.44 $11.4 Million - $14.5 Million
-407,844 Reduced 8.47%
4,409,575 $140 Million
Q3 2023

Nov 13, 2023

SELL
$35.27 - $42.24 $13.7 Million - $16.4 Million
-387,087 Reduced 7.44%
4,817,419 $170 Million
Q2 2023

Aug 11, 2023

SELL
$37.4 - $42.94 $1.62 Million - $1.86 Million
-43,354 Reduced 0.83%
5,204,506 $198 Million
Q1 2023

May 12, 2023

SELL
$34.88 - $43.22 $7.96 Million - $9.86 Million
-228,185 Reduced 4.17%
5,247,860 $198 Million
Q4 2022

Feb 13, 2023

BUY
$33.8 - $47.06 $6.97 Million - $9.7 Million
206,186 Added 3.91%
5,476,045 $232 Million
Q3 2022

Nov 14, 2022

SELL
$31.52 - $373.61 $5.51 Million - $65.3 Million
-174,904 Reduced 3.21%
5,269,859 $169 Million
Q2 2022

Aug 12, 2022

SELL
$26.83 - $38.57 $1.34 Million - $1.93 Million
-49,926 Reduced 0.91%
5,444,763 $177 Million
Q1 2022

May 12, 2022

BUY
$30.95 - $39.68 $2.68 Million - $3.44 Million
86,571 Added 1.6%
5,494,689 $199 Million
Q4 2021

Feb 10, 2022

SELL
$35.87 - $47.12 $51.9 Million - $68.2 Million
-1,446,846 Reduced 21.11%
5,408,118 $214 Million
Q3 2021

Nov 09, 2021

SELL
$41.55 - $48.72 $34.6 Million - $40.6 Million
-833,188 Reduced 10.84%
6,854,964 $300 Million
Q2 2021

Aug 11, 2021

BUY
$32.88 - $44.57 $253 Million - $343 Million
7,688,152 New
7,688,152 $314 Million

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.9B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.